RISEDRONATE VIATRIS 75 mg, film-coated tablet 2 tablets
Active ingredients: Risedronic acid, Risedronate sodium hemi-pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet2 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISEDRONATE VIATRIS 75 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 2 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Jun 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60582021CIP72740712CIP133400927407123Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISÉDRONATE MONOSODIQUE HÉMIPENTAHYDRATÉcomprimé | 75 mg · un comprimé | SA |
| ACIDE RISÉDRONIQUEcomprimé | 69,6 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.